Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
LakePharma has announced the launch of GMP manufacturing of recombinant proteins and antibodies with CHO-GSN™ and TunaCHO™ platforms at its Hayward, California facility.
read more
Monday, February 04, 2019
Lambda Therapeutic Research has reached an agreement to acquire Novum Pharmaceutical Research Services, a CRO in the U.S., in a private transaction. Terms were not disclosed.
read more
underwent a cGMP (Current Good Manufacturing Practices) on-site inspection by the FDA and received the EIR (Establishment Inspection Report) from the FDA. This is the fourth time that Langhua Pharmaceutical has undergone and passed the on-site ...
read more
Thursday, November 30, 2017
Lannett has entered into an agreement with Aralez to become the exclusive distributor in the U.S. of the authorized generic version of Toprol-XL.
read more
Lannett has entered into separate agreements with three strategic alliance partners.
read more
Lannett announced that effective July 1, 2018 current director, Patrick LePore, will become chairman of the board of directors, succeeding Jeffrey Farber, who will remain a member of the board.
read more
Lannett announced that it launched four products in June 2018, bringing to seven the total number of products launched since January 1, 2018.
read more
Lannett has announced a restructuring and cost reduction plan of its subsidiary, Cody Laboratories, a developer and manufacturer of pain management APIs.
read more
Lannett Company has announced two promotions. Kristie Stephens has been appointed vice president of regulatory affairs and chief compliance officer, and John Kozlowski has been appointed vice president financial operations and corporate controller.
read more
Friday, December 22, 2017
Lannett announced its board of directors has named Timothy C. Crew as the company's CEO, effective January 2, 2018.
read more
Monday, November 12, 2018
Lannett Company has entered into an agreement with Amneal Pharmaceuticals with regard to Levothyroxine Sodium Tablets USP.
read more
Wednesday, August 28, 2019
Lannett has entered into an agreement with Sinotherapeutics to be the exclusive U.S. distributor of Posaconazole Delayed-Release Tablets 100mg.
read more
Wednesday, January 23, 2019
Lannett entered into an agreement with a strategic alliance partner to be the exclusive U.S. distributor of Trientine Hydrochloride Capsules, 250 mg.
read more
Lannett Company has entered into a three-year agreement with Elite Pharmaceuticals to be the exclusive U.S. distributor of a Dantrolene Capsules 25 mg, 50 mg and 100 mg.
read more
Lannett announced it has entered into a future exclusive supply and distribution agreement for the approved Levothyroxine Sodium Tablets USP.
read more